TickerFactsScreenerDevelopers

Alaunos Therapeutics, Inc. (TCRT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2003: $02008: $11.38M2009: $48.84M2010: $60.39M2011: $104.71M2012: $73.31M2013: $68.20M2014: $42.80M2015: $140.72M2016: $81.05M2017: $70.95M2018: $61.73M2019: $79.74M2020: $115.07M2021: $76.05M2022: $39.06M2023: $6.06M2024: $1.09M2025: $1.39M$1.39M
2003Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.39M+26.9%
2024$1.09M-82.0%
2023$6.06M-84.5%
2022$39.06M-48.6%
2021$76.05M-33.9%
2020$115.07M+44.3%
2019$79.74M+29.2%
2018$61.73M-13.0%
2017$70.95M-12.5%
2016$81.05M-42.4%
2015$140.72M+228.8%
2014$42.80M-37.2%
2013$68.20M-7.0%
2012$73.31M-30.0%
2011$104.71M+73.4%
2010$60.39M+23.7%
2009$48.84M+329.2%
2008$11.38M—
2003$0—